Amber O. Molnar

2.5k total citations · 1 hit paper
60 papers, 1.6k citations indexed

About

Amber O. Molnar is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Amber O. Molnar has authored 60 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Nephrology, 19 papers in Cardiology and Cardiovascular Medicine and 12 papers in Surgery. Recurrent topics in Amber O. Molnar's work include Dialysis and Renal Disease Management (20 papers), Chronic Kidney Disease and Diabetes (13 papers) and Atrial Fibrillation Management and Outcomes (10 papers). Amber O. Molnar is often cited by papers focused on Dialysis and Renal Disease Management (20 papers), Chronic Kidney Disease and Diabetes (13 papers) and Atrial Fibrillation Management and Outcomes (10 papers). Amber O. Molnar collaborates with scholars based in Canada, United States and Australia. Amber O. Molnar's co-authors include Manish M. Sood, Amit X. Garg, Michael Walsh, P.J. Devereaux, Marko Mrkobrada, Lehana Thabane, Stephen D. Walter, Christine Ribic, Janice Pogue and Oren Levine and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Kidney International.

In The Last Decade

Amber O. Molnar

53 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index

2014 443 citations Michael Walsh, Amber O. Molnar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amber O. Molnar Canada	21	515	475	328	262	208	60	1.6k
Edouard L. Fu Sweden	23	460 0.9×	480 1.0×	203 0.6×	157 0.6×	133 0.6×	82	1.7k
Azim S. Gangji Canada	17	175 0.3×	325 0.7×	302 0.9×	104 0.4×	86 0.4×	44	1.2k
Chava L. Ramspek Netherlands	16	209 0.4×	255 0.5×	177 0.5×	225 0.9×	108 0.5×	33	1.2k
Bernard Croal United Kingdom	23	973 1.9×	227 0.5×	603 1.8×	257 1.0×	48 0.2×	50	2.1k
Vidula Bhole Canada	14	415 0.8×	631 1.3×	473 1.4×	402 1.5×	173 0.8×	14	1.9k
Bart S. Ferket United States	26	545 1.1×	241 0.5×	699 2.1×	224 0.9×	191 0.9×	80	2.2k
Nicole Zytaruk Canada	22	218 0.4×	96 0.2×	817 2.5×	331 1.3×	72 0.3×	63	3.0k
Garth H. Utter United States	30	359 0.7×	143 0.3×	789 2.4×	301 1.1×	125 0.6×	95	2.3k
Gihad Nesrallah Canada	27	368 0.7×	1.7k 3.6×	555 1.7×	157 0.6×	315 1.5×	89	2.5k
Alice M. Mitchell United States	17	306 0.6×	298 0.6×	160 0.5×	140 0.5×	38 0.2×	40	1.3k

Countries citing papers authored by Amber O. Molnar

Since Specialization

Citations

This map shows the geographic impact of Amber O. Molnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber O. Molnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber O. Molnar more than expected).

Fields of papers citing papers by Amber O. Molnar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amber O. Molnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber O. Molnar. The network helps show where Amber O. Molnar may publish in the future.

Co-authorship network of co-authors of Amber O. Molnar

This figure shows the co-authorship network connecting the top 25 collaborators of Amber O. Molnar. A scholar is included among the top collaborators of Amber O. Molnar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amber O. Molnar. Amber O. Molnar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ray, Joel G., Kevin Yau, Nivethika Jeyakumar, et al.. (2025). SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors. JAMA Internal Medicine. 185(7). 827–827. 2 indexed citations

Junek, Mats, et al.. (2025). Assessment of Giant Cell Arteritis–Associated Visual Outcomes at a Tertiary Hospital in Ontario, Canada. The Journal of Rheumatology. 52(12). 1274–1280.

Molnar, Amber O.. (2025). In active lupus nephritis, adding obinutuzumab to standard therapy increased complete renal response rates at 76 wk. Annals of Internal Medicine. 178(6). JC68–JC68. 1 indexed citations

Smyth, Andrew, Amber O. Molnar, Paul Moayyedi, et al.. (2024). The Effects of Pantoprazole on Kidney Outcomes. Journal of the American Society of Nephrology. 35(7). 901–909. 2 indexed citations

Mallick, Ranjeeta, Emily Rhodes, Anan Bader Eddeen, et al.. (2023). Development and Validation of a Predictive Risk Algorithm for Bleeding in Individuals on Long-term Hemodialysis: An International Prospective Cohort Study (BLEED-HD). Canadian Journal of Kidney Health and Disease. 10. 1035124810–1035124810. 4 indexed citations

Brimble, K. Scott, Allan Grill, Amber O. Molnar, et al.. (2020). Impact of the KidneyWise toolkit on chronic kidney disease referral practices in Ontario primary care: a prospective evaluation. BMJ Open. 10(2). e032838–e032838. 9 indexed citations

Molnar, Amber O., Sarah E. Bota, Nivethika Jeyakumar, et al.. (2020). Potentially inappropriate prescribing in older adults with advanced chronic kidney disease. PLoS ONE. 15(8). e0237868–e0237868. 16 indexed citations

McArthur, Eric, Sarah E. Bota, Ziv Harel, et al.. (2020). Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants. American Journal of Kidney Diseases. 76(3). 311–320. 17 indexed citations

Molnar, Amber O., Sarah E. Bota, Amit Garg, et al.. (2020). Dialysis Modality and Mortality in Heart Failure: A Retrospective Study of Incident Dialysis Patients. Cardiorenal Medicine. 10(6). 452–461. 3 indexed citations

10.

Collister, David, Maoliosa Donald, Amber O. Molnar, et al.. (2019). Multidisciplinary Chronic Kidney Disease Clinic Practices: A Scoping Review. Canadian Journal of Kidney Health and Disease. 6. 2247761835–2247761835. 40 indexed citations

11.

Massicotte‐Azarniouch, David, Anan Bader Eddeen, Amber O. Molnar, et al.. (2017). Risk of Venous Thromboembolism in Patients by Albuminuria and Estimated GFR. American Journal of Kidney Diseases. 70(6). 826–833. 17 indexed citations

12.

Harel, Ziv, Glenn M. Chertow, Prakesh S. Shah, et al.. (2017). Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis. Canadian Journal of Cardiology. 33(6). 737–746. 54 indexed citations

13.

Molnar, Amber O., Ayub Akbari, Manish M. Sood, et al.. (2016). The association of urinary sodium excretion and the need for renal replacement therapy in advanced chronic kidney disease: a cohort study. BMC Nephrology. 17(1). 123–123. 10 indexed citations

14.

Kim, Richard B., Eric McArthur, Jamie L Fleet, et al.. (2016). Statin Safety in Chinese: A Population-Based Study of Older Adults. PLoS ONE. 11(3). e0150990–e0150990. 13 indexed citations

15.

McArthur, Eric, Ron Wald, Ziv Harel, et al.. (2016). The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation. Kidney International. 91(4). 928–936. 35 indexed citations

16.

Molnar, Amber O., Dean Fergusson, Anne Tsampalieros, et al.. (2015). Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis. BMJ. 350(jun22 4). h3163–h3163. 55 indexed citations

17.

Brown, Pierre Antoine, Ayub Akbari, Amber O. Molnar, et al.. (2015). Factors Associated with Unplanned Dialysis Starts in Patients followed by Nephrologists: A Retropective Cohort Study. PLoS ONE. 10(6). e0130080–e0130080. 40 indexed citations

18.

Sood, Manish M., Amit X. Garg, Sarah E. Bota, et al.. (2015). Risk of Major Hemorrhage after Kidney Transplantation. American Journal of Nephrology. 41(1). 73–80. 15 indexed citations

19.

Knoll, Greg, et al.. (2014). Vitamin D and kidney transplant outcomes: a protocol for a systematic review and meta-analysis. Systematic Reviews. 3(1). 64–64. 15 indexed citations

20.

Molnar, Amber O., Steven G. Coca, P.J. Devereaux, et al.. (2011). Statin Use Associates with a Lower Incidence of Acute Kidney Injury after Major Elective Surgery. Journal of the American Society of Nephrology. 22(5). 939–946. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact